- Title: Subtitle
- 784: VOLIXIBAT FOR THE TREATMENT OF CHOLESTATIC PRURITUS IN PRIMARY BILIARY CHOLANGITIS: AN ADAPTIVE, RANDOMIZED, PLACEBO-CONTROLLED PHASE 2B TRIAL (VANTAGE): INTERIM RESULTS
- Creators
- Kris V. KowdleyMitchell L. ShiffmanDebra WeinsteinVictor Ankoma-SeyNimer AssyDian-Jung ChiangMaurizia R. BrunettoJonel TrebickaCurtis FreedlandLisa FormanAntonio J. SanchezAlan BonderQiang CaiHrishikesh SamantNatasha Von RoennJohn E. EatonNyingi KemmerJiten P. KothadiaChirag PatelSuresh V. VenkatachalapathyEhud ZigmondEli ZuckermanRoberto Firpi-MorellTh. Till WissniowskiBrian BorgHesham ElGouhariManish ThaparNeha AgrawalJustin BoikeFrancois HabersetzerAna LleoAlexandre LouvetRoger McCorryGuy NeffColeman SmithAlbert TranRaffaella ViganoFrank E. UschnerMaximilian J. BrolYooyun ChungIlkay ErgencTiago NunesHallam GugelmannJayshree KrishnaswamiWill GarnerJoanne QuanPamela VigMichael A. Heneghan
- Resource Type
- Abstract
- Publication Details
- Gastroenterology (New York, N.Y. 1943), Vol.169(1), pp.S-181-S-182
- DOI
- 10.1016/S0016-5085(25)01368-X
- ISSN
- 0016-5085
- Language
- English
- Date published
- 05/2025
- Academic Unit
- Gastroenterology and Hepatology; Internal Medicine
- Record Identifier
- 9984845449302771
Abstract
784: VOLIXIBAT FOR THE TREATMENT OF CHOLESTATIC PRURITUS IN PRIMARY BILIARY CHOLANGITIS: AN ADAPTIVE, RANDOMIZED, PLACEBO-CONTROLLED PHASE 2B TRIAL (VANTAGE): INTERIM RESULTS
Gastroenterology (New York, N.Y. 1943), Vol.169(1), pp.S-181-S-182
05/2025
DOI: 10.1016/S0016-5085(25)01368-X
Details
Metrics
1 Record Views